Bausch Health
BHC
#4211
Rank
ยฃ1.92 B
Marketcap
ยฃ5.20
Share price
-6.10%
Change (1 day)
-21.63%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): ยฃ0.72

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is ยฃ0.73. In 2024 the company made an earnings per share (EPS) of -ยฃ0.09005 an increase over its 2023 EPS that were of -ยฃ1.22.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ0.72-903.72%
2024-ยฃ0.09005-92.59%
2023-ยฃ1.22160.89%
2022-ยฃ0.47-76.64%
2021-ยฃ1.9968.45%
2020-ยฃ1.18-68.91%
2019-ยฃ3.81-57.11%
2018-ยฃ8.88-272.22%
2017ยฃ5.16-199.29%
2016-ยฃ5.19798.7%
2015-ยฃ0.58-128.31%
2014ยฃ2.04-204.62%
2013-ยฃ1.95602.7%
2012-ยฃ0.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-ยฃ0.71-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-ยฃ0.18-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA